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Mercury (Hg) is ubiquitous in the global 
environment with both natural and anthro-
pogenic origins (Gundacker et al. 2007; 
Oken and Bellingerb 2008). There has been 
increasing concern regarding the detrimen-
tal effects of Hg on human health (Counter 
and Buchanan 2004). Hg has toxic effects 
on a wide variety of systems, particularly the 
central nervous system, kidneys, and skin 
(Brodsky et al. 1985). Moreover, exposure 
to methylmercury (MeHg) can have neuro-
toxic effects through oxidative stress (Castoldi 
et al. 2001). In particular, pregnant women, 
fetuses, and infants are quite susceptible to 
the toxic effects of Hg (Jedrychowski et al. 
2006; Trasande et al. 2005). Previous studies 
have reported that intrauterine exposure to 
total Hg is associated with neurobehavioral 
dysfunction in children (Jedrychowski et al. 
2006; Lederman et al. 2008).
In addition, the reproductive toxicity of 
MeHg and Hg vapor has been confirmed in 
many animal studies (Beyrouty and Chan 
2006; Fredriksson et al. 1993; Morgan 
et al. 2002). In humans, several studies have 
reported a relationship between occupational 
Hg exposure and adverse reproductive out-
comes, such as spontaneous abortion, growth 
retardation, congenital malformation, and 
fetal death (Seidler et al. 1999; Sikorski 
et al. 1987). However, studies examining 
Hg exposure in relation to birth weight have 
shown conflicting results. Some studies have 
reported an inverse association between the 
birth weight and the MeHg concentration 
in maternal and cord blood (Foldspang and 
Hansen 1990) and total Hg levels in the new-
born and maternal hair (Sikorski et al. 1986; 
Xue et al. 2007), whereas others have shown 
no such association (Grandjean et al. 2001; 
Lederman et al. 2008; Lucas et al. 2004; 
Marques et al. 2008). This variability may be 
mediated partly by genetic variations.
It has been suggested that glutathi-
one (GSH) plays an important role in Hg 
metabolism (Custodio et al. 2005). Both 
inorganic Hg and MeHg bind to GSH, pos-
sibly through a process catalyzed by gluta-
thione S-transferase (GST) (Engström et al. 
2008; Gundacker et al. 2007), and stable 
GSH–metal conjugates are eliminated in the 
feces and urine (Ballatori 2002; Ballatori and 
Clarkson 1985). GSTs are phase II xenobi-
otic metabolizing enzymes that catalyze the 
conjugation of a variety of electrophilic com-
pounds with GSH (Hayes and Strange 2000). 
Glutathione S-transferase M1 (GSTM1) and 
glutathione S-transferase T1 (GSTT1) genes 
are polymorphic in the human population 
(Schneider et al. 2004; Wormhoudt et al. 
1999). GSTM1 and GSTT1 null genes are 
the result of two homozygous deletions that 
result in a loss of functional activity (Jain et al. 
2006). However, there is inconsistency in the 
relationship between GSTT1 and GSTM1 
polymorphisms and Hg level. Gundacker 
et al. (2007) reported that the double-  deleted 
homozygous genotypes for GSTT1 and 
GSTM1 were associated with a higher hair Hg 
levels, whereas the GSTM1/GSTT1 genotype 
was not related to the retention of MeHg, 
as measured by the erythrocyte total Hg or 
inorganic Hg in the whole blood, plasma, and 
urine (Custodio et al. 2004, 2005).
On the other hand, Hg exposure causes 
oxidative stress through the formation of free 
radicals or an alteration of the antioxidant 
capacity of cells (Hussain et al 1997; Lund 
et al. 1993), and Hg-induced oxidative stress 
might interfere with normal intrauterine 
growth (Kim et al. 2005). However, GSH may 
scavenge the reactive oxygen species generated 
by Hg exposure (Pinheiro et al. 2008), and 
the GSTM1 (Park et al. 2008) and GSTT1 
(Dusinská et al. 2001) null genotypes have 
been associated with increased   oxidative stress.
To date, the relationships among Hg expo-
sure, birth weight, and GST polymorphisms 
have not yet been examined. Therefore, this 
study examined whether a GST polymorphism 
can modify the association between intra-
uterine Hg exposure and birth weight.
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Ba c k g r o u n d: Mercury (Hg) is toxic to both the reproductive and nervous systems. In addition, 
glutathione S-transferases (GSTs), which conjugate glutathione to a variety of electrophilic com-
pounds, are involved in the detoxification of Hg.
oB j e c t i v e: In this study we examined the association between prenatal exposure to Hg and birth 
weight as well as the influence of GST polymorphisms.
Me t h o d s : The total Hg concentration in maternal and cord blood was measured from 417 Korean 
women and newborns in the Mothers and Children’s Environmental Health study from 2006 to 
2008. Information on birth weight was collected from the patients’ medical records. The genotyp-
ing of glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) poly-
morphisms was carried out using polymerase chain reaction. Regression analysis was performed to 
determine the association between the blood Hg concentration and birth weight in mothers with 
GSTM1 and GSTT1 polymorphisms.
re s u l t s: The geometric mean levels of Hg in the maternal blood during late pregnancy and in cord 
blood were 3.30 µg/L and 5.53 µg/L, respectively. For mothers with the GSTT1 null genotype, 
elevated Hg levels in maternal blood during late pregnancy were associated with an increased risk of 
lower birth weight. For mothers with both GSTM1 and GSTT1 null genotype, both maternal and 
cord blood Hg levels were associated with lower birth weight.
co n c l u s i o n s: This study suggests that the interactions of Hg with GSTM1 and GSTT1 polymor-
phisms play a role in reducing birth weight.
key w o r d s : birth weight, GSTM1, GSTT1, mercury, polymorphism, pregnancy. Environ Health 
Perspect 118:437–443 (2010).  doi:10.1289/ehp.0900731 available via http://dx.doi.org/ [Online 
23 October 2009]Lee et al.
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Materials and Methods
Study population and data collection. This 
study is based on the Mothers and Children’s 
Environmental Health (MOCEH) study, 
which is a multicenter prospective cohort 
study. The MOCEH study has been carried 
out since 2006 to determine the effects of 
maternal environmental exposure on fetal and 
postnatal growth or development. All preg-
nant women living in the targeted study site 
(i.e., Seoul, Cheonan, and Ulsan) who are in 
the first trimester of pregnancy at the time of 
screening are eligible. The study protocol was 
approved by the institutional review boards at 
Ewha Woman’s University (Seoul), Dankook 
University Hospital (Cheonan), and Ulsan 
University Hospital (Ulsan, South Korea), 
and written informed consent was obtained 
from each woman.
At the time of this study, 957 pregnant 
women were enrolled in the MOCEH study, 
and the pregnancy outcomes of 629 women 
were followed up. The study subjects were 
restricted to those for whom maternal and 
cord blood Hg levels and GSTM1/GSTT1 
genotype were assessed. Overall, 445 partici-
pants were eligible for this study. Of these 445 
women, the following subjects were excluded: 
14 with multiple births, 1 with stillbirth, 1 
whose infant had a congenital anomaly, and 
12 who had preeclampsia or gestational dia-
betes mellitus. Finally, 417 pregnant women 
were enrolled in the analysis.
Data collection consisted of an inter-
viewed questionnaire, nutritional survey, 
and biological samples (blood and urine). 
Information on sociodemographic characteris-
tics, prior medical history, psychosocial status, 
health behavior, and environmental exposure 
was collected from an interview with trained 
nurses. Gestational age was estimated based 
on the onset of the last menstrual period; if 
the last menstrual period was unreliable or if 
there was a significant discordance between 
the ultrasonographic and last menstrual period 
dating (> 10 days), the first ultrasonographic 
estimation of the gestational age was used. 
Trained nurses in the delivery room routinely 
measured birth weight using a digital scale at 
birth and recorded it on the patient’s medical 
charts. Information on the birth outcome, 
such as birth weight, gestational age, parity, 
and infant sex, was collected from the medical 
records at delivery. A dietary assessment based 
on 24-hr recall of dietary intake on the day 
before the blood test was administered within 
20 gestational weeks. The food and nutri-
ent intake, including the amount of fish con-
sumption, was assessed using a computerized 
nutrient-intake assessment software program 
(CAN-Pro 3.0; Korean Nutrition Society, 
Seoul, Korea).
Hg analysis. The maternal blood samples 
were obtained during early pregnancy (12–20 
gestational weeks) and late pregnancy (28–42 
gestational weeks). The cord blood samples 
were collected at birth. The blood samples 
were stored at –70°C until analysis. Hg anal-
ysis was performed by flow injection cold-
vapor atomic absorption spectrometry (AAS) 
(DMA-80; Milestone, Bergamo, Italy). The 
sample was initially dried in an oxygen stream 
passed through a quartz tube located inside 
a controlled heating coil. The combustion 
gases were further decomposed on a catalytic 
column at 750°C. Hg vapor was collected 
on a gold amalgamation trap and then des-
orbed for quantification. The Hg content was 
determined by AAS. The laboratory analyses 
were carried out using standardized quality-
control procedures. An internal control was 
used for each series of analyses. The precision 
and accuracy of the Hg level measurement 
were verified by periodically participating in 
an external quality control program (inter-
laboratory calibration exercises). The limit 
of detection (LOD) was 0.158 µg/L, and no 
sample had an Hg level below the LOD.
Genotyping of GSTM1 and GSTT1. 
The genomic DNA was extracted from the 
whole blood using a QIAamp DNA blood kit 
(Qiagen, Valencia, CA, USA). GSTM1 and 
GSTT1 polymorphisms were genotyped using 
a polymerase chain reaction (PCR) approach. 
As a positive control, coamplification of the 
268-bp fragment of the β-globin gene was 
performed at the same time as the analysis of 
the GSTM1 and GSTT1 polymorphisms. The 
PCR mixture (20 µL) for GSTM1 and GSTT1 
genotyping contained 10 mM Tris-HCl (pH 
9.0), 40 mM KCl, 1.5 mM MgCl2, 0.25 mM 
of each dNTP, 1 unit Taq polymerase 
Table 1. Characteristics of the mothers and infants.
Birth weight (g)
Characteristic n (%) Mean 95% CI p-Value
Maternal characteristics
Age (years)
< 30 187 (44.8) 3313.0 3250.6–3375.5 0.22
30 to < 35 178 (42.8) 3273.9 3217.7–3330.0
≥ 35 52 (12.5) 3200.6 3057.3–3343.8
Prepregnancy BMI (kg/m2)
< 18.5 55 (13.3) 3170.5 3073.4–3267.5 0.02
18.5 to < 23.0 233 (56.4) 3274.4 3222.6–3326.2
≥ 23.0 125 (30.3) 3361.2 3277.6–3444.8
Education (years) 
< 12  135 (33.7) 3275.7 3197.9–3353.4 0.94
≥ 12  265 (66.3) 3279.0 3229.3–3328.7
Fish consumption (g/day)
≤ 150 344 (90.0) 3267.3 3221.8–3312.9 0.17
> 150 39 (10.0) 3367.1 3230.1–3504.0
GSTM1
Present 169 (40.5) 3289.6 3225.2–3353.9 0.77
Null 248 (59.5) 3277.3 3224.5–3330.2
GSTT1
Present 195 (46.8) 3262.8 3199.4–3326.1 0.37
Null 222 (53.2) 3299.4 3246.6–3352.3
Infant characteristics
Sex
Male 207 (49.6) 3315.8 3253.9–3377.6 0.11
Female 210 (50.4) 3249.3 3196.1–3249.3
Parity
0 109 (28.1) 3292.7 3215.6–3369.8 0.99
1 177 (45.6) 3287.9 3218.6–3357.2
≥ 2 102 (26.3) 3282.8 3211.6–3354.1
Gestational age (weeks)
< 37 14 (3.4) 2512.1 2168.3–2855.9 < 0.01
≥ 37 403 (96.6) 3309.0 3270.8–3347.3
Birth weight (g)
< 2,500 7 (1.7) 2074.3 1513.4–2635.2 < 0.01
≥ 2,500 410 (98.3) 3302.9 3265.2–3340.7
Numbers within subgroups vary slightly because of missing values for some variables.
Table 2. GMs and percentiles of total Hg concentration (µg/L) in maternal and cord blood.
Percentile
Sample GM Range 10th 25th 50th 75th 90th
Maternal blood
Early pregnancy 3.67 0.27–22.6 1.79 2.59 3.85 5.20 6.65
Late pregnancy 3.30 0.12–18.5 1.80 2.45 3.23 4.45 6.27
Cord blood  5.53 0.23–24.1 3.10 4.19 5.54 7.59 9.57Effects of GSTM1/GSTT1 polymorphism and mercury on birth weight
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(Bioneer, Seoul, Korea), 20 pmol of the for-
ward and reverse primers, and 50–100 ng of 
the genomic DNA as a template. The follow-
ing primer sets for the GSTM1 and GSTT1 
genes were used for the amplification reaction: 
5´-GAACTCCCTGAAAAGCTAAAGC-3´ 
(forward) and 5´-GTTGGGCT  CAAA 
TATACGGTGG-3´ (reverse) for GSTM1, 
and 5´-TCACCGGATCATGGCCAGCA-3´ 
(forward) and 5´-TTCCTTAC  TG  GT  CC 
TC  ACATCTC-3´ (reverse) for GSTT1. The 
amplifications were performed under the fol-
lowing conditions: initial denaturation at 
94°C for 5 min; 35 cycles of denaturation at 
94°C for 1 min, annealing at 65°C for 1 min, 
and extension at 72°C for 1 min; and a final 
extension at 72°C for 7 min. PCR amplifica-
tion of the reaction mixtures was carried out 
using a PTC-200 thermal cycler (MJ Research, 
Watertown, MA, USA).
To evaluate the PCR-amplified fragments, 
electrophoresis on 3% 3:1 NuSieve/agarose 
gel was used (Cambrex Bio Science, Rockland, 
ME, USA). Genotyping of the GSTM1 and 
GSTT1 genes was performed based on the 
presence of a 215-bp product and 459-bp 
product, respectively. The null genotype was 
defined as a homozygous deletion of the gene. 
To confirm the analyses, 10% of the samples 
were selected randomly and genotyped again, 
with identical results.
Statistical analysis. Descriptive analyses 
were given for characteristics of the study sub-
jects, and birth weight according to maternal 
and infant characteristics was evaluated using 
t-test or analysis of variance. After descriptive 
analyses, Hg concentrations were transformed 
logarithmically because of their skewed distribu-
tion. The geometric means (GMs) and percen-
tiles for Hg concentrations were calculated. The 
relationship between Hg concentration and risk 
factors were examined using a Wilcoxon rank-
sum test or Kruskal–Wallis rank sum test.
We used regression analysis to examine the 
effects of Hg levels in the maternal and cord 
blood on the birth weight in mothers with the 
GSTM1 or GSTT1 genotype. The covariates 
in the multiple regression models were cho-
sen as follows: First, the risk factors associated 
with Hg exposure or birth weight were identi-
fied from the literature. Second, the variable 
was considered to be a potential confounder 
if the variables were related to birth weight 
or Hg level at p < 0.20 in univariate analyses. 
Covariates included the indicator variables 
for infant sex, maternal age (< 30, 30 to < 35, 
≥ 35 years), prepregnancy body mass index 
(BMI; < 18.5, 18.5 to < 23, ≥ 23 kg/m2), 
maternal educational level (< 12, ≥ 12 years), 
parity (0, 1, ≥ 2), and continuous variables for 
gestational age (weeks) and weight gain (kilo-
grams). In addition, information on amal-
gam fillings was collected, but there was no 
correlation between the presence of amalgam 
fillings and blood Hg levels. Therefore, amal-
gam fillings were not included in the analyses. 
Some participants had missing data for a par-
ticular variable and were excluded from multi-
variate analysis. To examine interactive effect 
of the genotypes and Hg on birth weight, we 
included an interaction term between Hg level 
and genotypes in the multivariate analysis. 
After identifying the interaction effect, strati-
fied analysis was performed by genotypes of 
GSTM1/GSTT1, and combined effects 
of GSTM1 and GSTT1 genotype were also 
assessed using regression analysis.
In the generalized linear model, analysis 
of covariance was carried out for birth weight, 
and the least-square mean of birth weight 
according to GSTM1 and GSTT1 polymor-
phism and Hg level was estimated. The aver-
age Hg level during pregnancy was divided 
into three categories according to a tertile 
distribution, and GSTM1/GSTT1 genotype 
was classified as both present, either null, and 
double null. All statistical analyses were car-
ried out using SAS statistical software (version 
8.2; SAS Institute Inc., Cary, NC, USA).
Results
All participants were of Korean ethnicity. The 
mean maternal age was 30.1 years, and 66.3% 
of the participants had completed > 12 years of 
education. The prevalence of the null geno-
type for GSTM1 and GSTT1 was 59.5% and 
53.2%, respectively. The mean ± SD birth 
weight for newborns was 3,282 ± 433 g. 
Approximately 97% of the infants were born at 
term. The birth weight increased with increas-
ing BMI at prepregnancy and gestational age 
(Table 1).
Table 2 shows the distribution of Hg con-
centrations. The GM of the maternal blood Hg 
concentration was 3.67 µg/L during early preg-
nancy and 3.30 µg/L during late pregnancy. 
The levels of cord blood Hg were higher than 
the concentration of maternal blood Hg.
Hg levels in the cord blood correlated with 
that in the maternal blood during late preg-
nancy (Pearson r = 0.72, p < 0.0001). When 
we analyzed the relationship between mater-
nal and cord blood according to GSTM1 and 
GSTT1 genotype (Figure 1), we found that 
the regression lines by GSTM1 genotype were 
somewhat different but did not reach statisti-
cal significance (p = 0.59). For GSTT1 gen-
otype, we observed no significant difference 
(p = 0.91).
As shown in Table 3, maternal blood Hg 
in late pregnancy and Hg in cord blood were 
significantly higher in women with a higher 
educational level. Hg concentration during 
late pregnancy was higher in pregnant women 
who ate > 150 g fish per day. However, we 
found no difference in Hg level according to 
GSTM1 or GSTT1 genotype.
Table 4 shows the relationship between 
Hg level and birth weight according to 
Figure 1. Relationship between cord blood and maternal blood Hg by GSTM1 (A) and GSTT1 (B) genotype.
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GSTM1/GSTT1 genotype. Overall, we found 
an inverse relationship between birth weight 
and maternal and cord blood Hg levels. The 
birth weight of newborns whose mothers had 
the GSTM1 null type decreased with increas-
ing cord blood Hg level. Birth weight also 
decreased with increasing maternal Hg level in 
late pregnancy in newborns whose mothers had 
the GSTT1 null type. However, we found no 
significant inverse relationship between Hg level 
and birth weight in the GSTM1 and GSTT1 
present genotypes. In early pregnancy, the birth 
weight decreased with increasing Hg level but 
not significantly, and GSTM1 or GSTT1 geno-
type did not affect the relationship. We found 
similar results that did not reach statistical 
significance when we carried out multivariate 
analysis after excluding the preterm births.
Table 5 shows joint effect estimates for Hg 
level and GSTM1/GSTT1 polymorphisms. 
Subjects whose Hg levels in late pregnancy 
exceeded the 90th percentile had significantly 
lower birth weight compared with subjects 
with Hg levels less than the 90th percentile. 
The interaction term for GSTM1 and Hg level 
in early pregnancy was significant, whereas 
the interaction of GSTM1 and Hg level dur-
ing late pregnancy was marginally significant. 
We also found that the interaction between 
cord blood Hg and GSTM1 genotype was 
marginally significant. On the other hand, 
the interaction between Hg level in early or 
late pregnancy and GSTT1 genotype was not 
significant. In addition, we found no signifi-
cant interactions between cord blood Hg and 
GSTT1 genotype.
Table 6 shows the results of combined 
analysis considering the GSTM1 and GSTT1 
genotype simultaneously. In both present 
types, Hg exposure in the mother and neo-
nates was not associated with birth weight. 
For either null type, Hg level in early preg-
nancy was related to a decrease in birth weight 
but not with Hg level in late pregnancy or 
in the cord blood. In the case of both null 
types, Hg levels in maternal blood during 
late pregnancy and cord blood were inversely 
associated with birth weight. We found simi-
lar results among the subsample of infants 
excluding preterm births, but statistical sig-
nificance was not reached.
We found significant differences in the 
least-square means of birth weight according 
to the combination of GSTM1 and GSTT1 
polymorphisms and Hg exposure (Figure 2). 
We found decreased birth weight according 
to increasing Hg level in women with either 
a GSTM1 or a GSTT1 deletion. Among the 
women carrying either deletion, we found a 
significant difference in the least-square means 
of birth weight by maternal Hg level during 
pregnancy (i.e., first tertile or second tertile vs. 
third tertile Hg). In addition, we observed a 
marginally significant decrease in birth weight 
in women with a GSTM1/GSTT1 double 
deletion and high blood Hg level, compared 
with women with a double deletion and low 
blood Hg level.
Discussion
In this study we found that a GST polymor-
phism may modify the relationship between 
prenatal exposure to Hg and birth weight. 
Hg concentration in maternal blood and 
cord blood was significantly associated with a 
decreased birth weight. In particular, this ten-
dency was more obvious in women who were 
GSTM1/GSTT1 double null. Even a small 
shift in the mean birth weight curve toward 
Table 3. Distribution of maternal and cord blood Hg concentration (µg/L) by maternal characteristics. 
Maternal blood Hg
During early pregnancy During late pregnancy Cord blood Hg
Characteristic Median p-Valuea Median p-Valuea Median p-Valuea
Age (years)
< 30 3.96 0.85 3.20 0.13 5.62 0.26
30 to < 35 3.84 3.35 5.64
≥ 35 3.57 3.04 5.06
BMI at prepregnancy (kg/m2)
< 18.5 3.54 0.66 3.83 0.28 6.03 0.50
18.5 to < 23.0 3.66 3.19 5.48
≥ 23.0 4.13 3.37 5.74
Education (years)
< 12 3.66 0.27 3.09 0.04 5.01 < 0.01
≥ 12 3.89 3.38 5.78
Fish consumption (g/day)
≤ 150 3.76 0.32 3.16 0.03 5.54 0.18
> 150 4.27 3.95 5.75
GSTM1
Present 3.90 0.77 3.30 0.90 5.53 0.88
Null 3.69 3.21 5.58
GSTT1
Present 3.95 0.70 3.22 0.53 5.54 0.42
Null 3.67 3.26 5.56
ap-Value calculated by the Wilcoxon rank sum test or Kruskal–Wallis rank sum test because of the skewness of the 
Hg data.
Table 4. Regression coefficients and 95% confidence intervals for Hg level associated with birth weight according to GSTM1/GSTT1 genotype.
Exposure period of total 
Hg (log scale of µg/L)
Adjusteda
Unadjusted Full sample Subsample excluding preterm births
Genotype β 95% CI β 95% CI β 95% CI
Early pregnancy Total  –4.4 –79.5 to 70.8 –68.6 –138.6 to 1.5 –51.4 –122.2 to 19.5
GSTM1 present 66.8 –55.6 to 189.2 –37.5 –154.6 to 79.7 –37.8 –155.4 to 79.8
GSTM1 null –48.3 –143.9 to 7.3 –79.5 –168.9 to 9.9 –47.9 –138.8 to 43.0
GSTT1 present 9.1 –109.7 to 128.0 –50.7 –158.7 to 57.3 –24.0 –137.8 to 89.9
GSTT1 null –13.7 –110.2 to 82.7 –70.2 –166.5 to 26.0 –63.8 –157.9 to 30.3
Late pregnancy Total  –27.1 –103.1 to 49.0 –65.5 –135.6 to 4.5 –40.1 –110.9 to 30.0
GSTM1 present 39.2 –89.1 to 167.5 –34.3 –153.7 to 85.1 –22.7 –144.6 to 99.3
GSTM1 null –64.4 –159.3 to 30.4 –84.8 –171.4 to 1.7 –57.3 –143.8 to 29.3
GSTT1 present 3.3 –124.6 to 131.1 –25.6 –140.4 to 89.2 –5.7 –122.4 to 111.0
GSTT1 null –49.1 –142.1 to 44.0 –99.0 –189.2 to –8.8 –66.8 –156.7 to 23.1
Cord blood Total  –33.0 –116.1 to 49.9 –86.4 –163.1 to –9.7 –65.2 –143.0 to 12.5
GSTM1 Present 54.9 –88.9 to 198.6 –68.3 –206.6 to 70.1 –59.6 –199.5 to 80.3
GSTM1 null –78.5 –180.5 to 23.5 –107.3 –199.7 to –14.8 –74.7 –168.5 to 19.2
GSTT1 Present –39.5 –162.2 to 83.1 –77.7 –187.6 to 32.3 –54.9 –168.2 to 58.4
GSTT1 null –30.5 –144.3 to 83.4 –101.0 –212.3 to 10.4 –76.5 –187.6 to 34.6
aMultivariate regression models included gestational age, prepregnancy BMI, maternal age, mother’s educational level, infant sex, parity, and weight gain during pregnancy as covariates.Effects of GSTM1/GSTT1 polymorphism and mercury on birth weight
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the left could cause a public health burden, 
which would be enhanced among these sus-
ceptible groups. 
To the best of our knowledge, this is the 
first study to demonstrate gene–environment 
interactions in the association between Hg 
exposure and birth weight.
In this study, the GMs of the total Hg 
concentrations in the maternal blood during 
early and late pregnancy were 3.67 µg/L and 
3.30 µg/L, respectively. In contrast, the GM 
of Hg levels in cord blood was 5.53 µg/L, 
which is higher than that of the maternal 
blood. The blood total Hg concentration in 
this study was relatively high compared with 
concentrations reported in other studies. 
In a recent study performed in the United 
States, Lederman et al. (2008) reported a GM 
total Hg level for maternal and cord blood of 
1.6 µg/L and 4.44 µg/L, respectively. Among 
pregnant women living in Quebec, the GM of 
blood total Hg level at delivery was 0.48 µg/L 
(Morrissette et al. 2004). Jedrychowski et al. 
(2007) reported an average total Hg concen-
tration of 0.83 µg/L in mothers at delivery and 
1.09 µg/L in newborns. In contrast, the GM of 
the blood total Hg concentration in pregnant 
women in Taiwan and Greenland was 8.6 µg/L 
and 12.8 µg/L, respectively (Bjerregaard and 
Hansen 2000; Hsu et al. 2007). In the present 
study, 13.2% of the maternal blood Hg lev-
els during late pregnancy exceeded 5.8 µg/L, 
which is the value recommended by the U.S. 
Environmental Protection Agency to moni-
tor Hg concentrations in blood. Our finding 
of the higher Hg concentrations in the cord 
blood than in the maternal blood was con-
sistent with previous studies. This finding 
can partly be explained by the fact that Hg is 
transferred to the fetus through the placenta 
(Kajiwara et al. 1996; Morrissette et al. 2004) 
and has a high affinity to fetal hemoglobin 
(Hsu et al. 2007; Iyengar and Rapp 2001), 
which is consistent with the observation that 
newborns show a larger hematocrit than do 
their mothers (Stern and Smith 2003).
The relationship between Hg exposure and 
pregnancy outcomes is controversial, particu-
larly for low birth weight. Only a few stud-
ies have examined these associations, and the 
published results are inconsistent. Sikorski 
et al. (1986) assessed the concentration of total 
Hg in the hair of newborns and found that 
infants with a scalp hair Hg concentration of 
> 0.07 mg/kg had a 361-g lower mean birth 
weight than did infants with lower concentra-
tions. In Greenland, Foldspang and Hansen 
(1990) reported that higher maternal and off-
spring MeHg blood concentrations were asso-
ciated with low mean birth weight. A German 
study found that exposure to Hg among occu-
pational workers is associated with growth 
retardation of their newborns (Seidler et al. 
1999). These findings are in agreement with 
the present result that total Hg in maternal 
and cord blood is associated with decreased 
birth weight. In addition, in animal studies, 
Table 5. Regression model testing main and interactive effects of blood Hg (µg/L) and GSTM1 or GSTT1 genotype on birth weight.
Early pregnancy Late pregnancy Cord blood
Model β p-Value β p-Value β p-Value
Model 1: GSTM1 interaction
Hg level (≥ 90th vs. < 90th) –114.9 0.18 –197.6 0.01 –215.4 0.007
GSTM1 (present vs. null type) –339.3 0.04 –272.8 0.07 –260.4 0.08
Interaction term of GSTM1*Hg level 298.5 0.04 243.8 0.06 231.3 0.07
Model 2: GSTT1 interaction
Hg level (≥ 90th vs < 90th) –73.7 0.40 –80.6 0.34 –64.8 0.43
GSTT1 (present vs. null type) –196.8 0.22 137.6 0.39 152.5 0.30
Interaction term of GSTT1*Hg level 158.0 0.26 –154.9 0.27 –166.3 0.20
Adjusted for gestational age, prepregnancy BMI, maternal age, mother’s educational level, infant sex, parity, and weight gain during pregnancy.
Table 6. Association of combined GSTM1 and GSTT1 genotype and Hg level with birth weight.
Adjusteda
Exposure period of total Hg 
level (log scale of µg/L)
Unadjusted Full sample Subsample excluding preterm births
Genotype β 95% CI β 95% CI β 95% CI
Early pregnancy Both presentb 130.7 –49.8 to 311.1 39.6 –144.8 to 224.0 39.6 –144.8 to 224.0
Either nullc  –27.3 –141.0 to 86.5 –129.4 –232.8 to –26.1 –99.2 –206.7 to 8.4
Double nulld  –27.6 –143.9 to 88.8 –39.9 –155.4 to 75.7 –26.0 –142.6 to 90.5
Late pregnancy Both presentb  104.4 –82.1 to 290.9 46.2 –134.7 to 227.1 46.2 –134.7 to 227.1
Either nullc  –33.11 –157.1 to 90.9 –74.8 –186.6 to 37.0 –29.9 –143.9 to 84.1
Double nulld  –62.8 –169.2 to 43.6 –102.8 –205.4 to –0.2 –89.1 –193.2 to 15.1
Cord blood Both presentb  13.3 –193.0 to 219.7 –13.6 –222.5 to 195.4 –13.6 –222.5 to 195.4
Either nullc  –17.6 –138.9 to 103.6 –93.9 –203.2 to 15.3 –48.2 –161.5 to 65.2
Double nulld  –105.0 –239.1 to 29.1 –138.4 –268.8 to –8.0 –117.9 –251.3 to 15.5
aMultivariate regression model included gestational age, prepregnancy BMI, maternal age, mother’s educational level, infant sex, parity, and weight gain during pregnancy as covari-
ates. bBoth GSTM1 and GSTT1 is present. cEither GSTM1 or GSTT1 is null. dBoth GSTM1 and GSTT1 are null. 
Figure 2. Estimated mean birth weight by maternal Hg tertile and GSTM1/GSTT1 genotypes. Least-square 
means were estimated in the generalized linear model, adjusting for gestational age, prepregnancy BMI, 
weight gain during pregnancy, maternal age, education, infant sex, and parity. The average Hg level dur-
ing pregnancy was divided into tertiles, and genotype was classified by combination of GSTM1 and GSTT1 
genotypes.
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neonates from dams exposed to higher lev-
els of metallic Hg (Hg0) weigh significantly 
less than the controls at birth (Morgan et al. 
2002), and average weights of the pups at 
birth were 7–10% lower in groups treated 
with MeHg during gestation compared with 
controls (Beyrouty and Chan 2006).
However, some studies do not support the 
relationship between Hg exposure and birth 
weight. In a fishing community in Denmark, 
total Hg concentration in cord blood was not 
correlated with birth weight (Grandjean et al. 
2001). Lederman et al. (2008) found that 
total Hg in neither cord nor maternal blood 
was related to newborn size. A recent British 
study showed that total Hg levels in umbilical 
cord tissue were not related to birth weight 
(Daniels et al. 2007). This disparity among 
studies might be due to differences in genetic 
predisposition, dietary patterns, and environ-
mental factors (Lederman et al. 2008).
In the present study we investigated the 
gene–environment interactions between 
blood Hg and GST polymorphisms on birth 
weight. The gene–environment interaction 
between Hg level in early pregnancy and 
GSTM1 polymorphism was significant. We 
also found a marginally significant interaction 
with Hg level during late pregnancy. Because 
of the half-life of Hg, these results suggest that 
early pregnancy exposure might be impor-
tant even though most birth weight gain is 
attained in the third trimester. Although we 
performed stratified analysis according to 
GSTM1/GSTT1 genotype, the decrease in 
birth weight was significantly associated with 
cord blood Hg levels in mothers who were 
GSTM1 null as well as with maternal blood 
Hg level during late pregnancy in mothers 
who were GSTT1 null. After excluding pre-
term births (3.4%) from the data, we found 
similar trends, but statistical significance was 
not sustained. To date, however, there are no 
reports of the relationship between Hg levels 
and birth weight according to GST genotype. 
Only a few studies observed a relationship 
between a GST polymorphism and Hg con-
centration. Gundacker et al. (2007) found 
that a double-deleted genotype for GSTT1 
and GSTM1 was associated with a higher hair 
Hg concentration. In this study, we found no 
significant difference in the maternal Hg levels 
in women with either a GSTM1 or a GSTT1 
polymorphism. Similarly, Custodio et al. 
(2004) reported that GSTM1 and GSTT1 
polymorphisms did not affect erythrocyte Hg 
concentrations. 
The mechanism for how a GST polymor-
phism modifies the relationship between Hg 
level and birth weight has not been elucidated. 
Hg has a high affinity for GSH, and binding 
and dissociation of the GSH–Hg complex are 
believed to control the movement of Hg as 
well as its toxic effects in the body (Clarkson 
1997). Among the GSH-related enzymes, 
GSTs may catalyze the intracellular binding 
reaction of Hg with GSH (Engström et al. 
2008; Gundacker et al. 2007). In particu-
lar, the roles of the two GST genes, GSTT1 
and GSTM1, are important in Hg metabo-
lism because the deletion type of GSTM1/
GSTT1 reduces catalytic activity, leading to 
the slower elimination of Hg (Custodio et al. 
2005; Hayes and Strange 2000). In the pres-
ent study we found that the total Hg level in 
maternal blood during late pregnancy or in 
cord blood was associated more significantly 
with a decreased birth weight in women with 
the double-deleted genotype than in women 
with the intact genotype or one of the null 
genotypes. The double-deletion polymor-
phism might be more important because this 
combination impairs the ability for detoxifica-
tion more and increases the susceptibility to 
Hg exposure (Gundacker et al. 2007).
Another plausible mechanism is a decrease 
in birth weight via oxidative stress accord-
ing to Hg exposure. Hg has been reported to 
cause oxidative stress, which may lead to lipid 
peroxidation and the generation of reactive 
oxygen species (Huang et al. 2008; Pinheiro 
et al. 2008). Hui et al. (2001) suggested that 
heavy metals, such as Hg and cadmium, might 
induce oxidative stress caused by changes 
in the GSH and/or ATP metabolism. Also, 
pregnancy is a condition that favors oxida-
tive stress, mainly due to the mitochondria-
rich placenta, which may also be enhanced by 
the presence of metal toxins (Casanueva and 
Viteriy 2003; Chen and Lin 1998). However, 
we found no effect of GSTM1/GSTT1 geno-
type on the relationship between maternal and 
cord blood Hg. This implies that an effect of 
GSTM1/GSTT1 on the association between 
Hg and birth weight might be mediated by 
genetic modification on the oxidative stress 
level induced by Hg rather than an effect of 
GSTM1/GSTT1 on the metabolism of Hg.
The major strengths of this study are the 
prospective cohort design, the collection of 
more reliable data from the medical records, 
and adjustment for important confounders 
potentially affecting Hg exposure and birth 
weight. We measured Hg levels in maternal 
and cord blood, which reflects the changes in 
recent exposure (Foldspang and Hansen 1990; 
Grandjean et al. 2001; Lucas et al. 2004). 
Nevertheless, Hg concentrations assessed in 
the first and third trimesters could reflect the 
exposure during early and late pregnancy 
because the mean half-life of MeHg in blood 
is approximately 45 days (range, 20–70 days) 
(Clarkson 1993; Smith and Farris 1996). 
Information on fish consumption was collected 
using 24-hr recall, which can result in recall 
bias and may not reflect dietary intake dur-
ing the entire period of pregnancy. However, 
there did not appear to be any differential 
recall bias, because the dietary survey was car-
ried out before the pregnancy outcome (Xue 
et al. 2007). In this study, the total Hg level in 
maternal and cord blood was assessed. Hence, 
the effect of specific forms of Hg could not 
be investigated. Although the blood Hg level 
did not consist entirely of MeHg, it is gener-
ally used to represent MeHg exposure because 
total Hg concentrations in whole blood reflect 
exposure to organic Hg, predominantly MeHg 
(Sanzo et al. 2001). Furthermore, cord blood 
Hg was almost entirely MeHg because the 
placenta does not present a barrier to MeHg 
(Kelman et al. 1982).
This study showed that GST gene poly-
morphisms may play important roles in the 
relationship between Hg level and birth 
weight. Although a single defective gene 
might be associated with decreased birth 
weight, these results suggest that a combined 
genotype of GSTM1 and GSTT1 should be 
considered. Therefore, these findings high-
light the need for new policy guidelines to 
reduce the level of Hg exposure in high-risk 
groups, particularly pregnant women with 
genetic susceptibility.
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